Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0001711279-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-11 | 2026-02-09 | KRYS | ROMANO KATHRYN | CAO | S - Sale+OE | $272.14 | -12.5K | 29.8K | -30% | -$3.40M |
| D | 2026-02-11 | 2026-02-09 | KRYS | ROMANO KATHRYN | CAO | G - Gift | $0.00 | -750 | 18.6K | -4% | $0 |
| D | 2026-02-11 | 2026-02-09 | KRYS | ROMANO KATHRYN | CAO | M - OptEx | $63.55 | +12.5K | 31.8K | +65% | +$794.4K |
| D | 2026-02-11 | 2026-02-09 | KRYS | ROMANO KATHRYN | CAO | M - OptEx | $0.00 | -12.5K | 12.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-09 | S | D | 400 | $275.68 | 19,414 | D | — | — | (F7) The transaction was executed in multiple trades ranging from $275.445 to $275.930. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 2 | Common | Common Stock | 2026-02-09 | S | D | 96 | $277.88 | 19,318 | D | — | — | (F8) The transaction was executed in a single trade. |
| 3 | Common | Common Stock | 2026-02-09 | G | D | 750 | $0.00 | 18,568 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-09 | S | D | 2,824 | $272.51 | 21,294 | D | — | — | (F4) The transaction was executed in multiple trades ranging from $272.1275 to $273.070. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Common | Common Stock | 2026-02-09 | S | D | 552 | $274.64 | 19,814 | D | — | — | (F6) The transaction was executed in multiple trades ranging from $274.305 to $274.815. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 6 | Common | Common Stock | 2026-02-09 | S | D | 928 | $273.71 | 20,366 | D | — | — | (F5) The transaction was executed in multiple trades ranging from $273.160 to $274.095. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 7 | Common | Common Stock | 2026-02-09 | S | D | 5,700 | $271.66 | 24,118 | D | — | — | (F3) The transaction was executed in multiple trades ranging from $271.105 to $272.095. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 8 | Common | Common Stock | 2026-02-09 | S | D | 2,000 | $270.56 | 29,818 | D | — | — | (F2) The transaction was executed in multiple trades ranging from $270.010 to $270.950. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 9 | Common | Common Stock | 2026-02-09 | M | A | 12,500 | $63.55 | 31,818 | D | — | — | |
| 10 | Derivative | Stock Option (Right to Buy) | 2026-02-09 | M | D | 12,500 | $0.00 | 12,500 | D | $63.55 · — to 2032-02-27 | 12,500 Common Stock | (F10) The options vested ratably over a four-year period beginning on February 28, 2022. |